MRNA vs PSX · rev $145.0M vs P/E 17, rev $83.54B
Moderna Inc (MRNA) versus Phillips 66 (PSX) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported PSX revenue for 2026-06-30 was $83.54B. Net income was $4.05B. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
MRNA currently screens at market cap $24.52B. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Not investment advice. Open the MRNA and PSX stock pages for the full models.
Not investment advice.